BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18425841)

  • 21. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
    Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
    Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
    Sodano C; Clauser P; Dietzel M; Kapetas P; Pinker K; Helbich TH; Gussew A; Baltzer PA
    Eur Radiol; 2020 Jun; 30(6):3371-3382. PubMed ID: 32065286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.
    Dorrius MD; Pijnappel RM; van der Weide Jansen MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Eur Radiol; 2012 Apr; 22(4):915-22. PubMed ID: 22076317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions.
    Ouyang Z; Ouyang Y; Zhu M; Lu Y; Zhang Z; Shi J; Li X; Ren G
    Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
    Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
    ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results.
    Yeung DK; Cheung HS; Tse GM
    Radiology; 2001 Jul; 220(1):40-6. PubMed ID: 11425970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of renal tumors by in vivo proton magnetic resonance spectroscopy.
    Sevcenco S; Krssak M; Javor D; Ponhold L; Kuehhas FE; Fajkovic H; Haitel A; Shariat SF; Baltzer PA
    World J Urol; 2015 Jan; 33(1):17-23. PubMed ID: 24609220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.
    Thakur SB; Brennan SB; Ishill NM; Morris EA; Liberman L; Dershaw DD; Bartella L; Koutcher JA; Huang W
    J Magn Reson Imaging; 2011 Apr; 33(4):855-63. PubMed ID: 21448950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.